Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05907564 · ClinicalTrials.gov registry record · NA

Aventus Thrombectomy System Pulmonary Embolism Clinical Study

A NA study of Cardiovascular Diseases and Pulmonary Embolism, sponsored by Inquis Medical.

Active
Registry status
NA
Development phase
130
Enrollment target
20
Study locations

NCT05907564: Active NA study of Cardiovascular Diseases and Pulmonary Embolism, sponsored by Inquis Medical.

NCT05907564 is a NA study of Cardiovascular Diseases and Pulmonary Embolism that is active but no longer recruiting, run by Inquis Medical. The registered enrollment target is 130 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The trial reports 20 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05907564, a NA study of Cardiovascular Diseases and Pulmonary Embolism, is active but no longer recruiting, sponsored by Inquis Medical.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
130 participants
Enrollment target
20
Study locations

Study Summary

Evaluate the safety and efficacy of the Aventus Thrombectomy System for aspiration thrombectomy in subjects with acute pulmonary embolism.

Primary Outcome

Mean Change in RV (right ventricle)/LV(left ventricle) Ratio at 48hrs compared to baseline

Interventions

  • DEVICE Thrombectomy

Study Locations (20)

California

  • NorthBay Medical Center - Fairfield
  • MemorialCare - Long Beach
  • El Camino Health - Mountain View
  • Sutter Health - Sacramento

Michigan

  • McLaren Health Care - Bay City
  • Henry Ford Hospital - Detroit
  • Ascension Providence - Southfield

Illinois

  • Northwestern University - Chicago
  • Alexian Brothers Medical Center - Elk Grove Village

New Jersey

  • Hackensack University Medical Center - Hackensack
  • Holy Name Medical Center - Teaneck

Arizona

  • Honor Health - Scottsdale

Connecticut

  • Hartford Hospital - Hartford

District of Columbia

  • Medstar - Washington D.C.

Georgia

  • Emory University - Atlanta

Trial Details

FieldValue
Enrollment Target 130 participants
Start Date 2023-09-20
Est. Completion 2026-10
Phase NA
Inquis Medical

1 total trials

What the registry record for NCT05907564 still lists

NCT05907564 is an interventional study that assigns participants to a tested intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower).

The record links to 7 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 1 intervention - of which Thrombectomy is the first listed.

NCT05907564 names 20 study sites across 13 states, led by California, Michigan, Illinois.

Frequently Asked Questions

What is clinical trial NCT05907564 about?

NCT05907564 is a clinical study titled "Aventus Thrombectomy System Pulmonary Embolism Clinical Study". Evaluate the safety and efficacy of the Aventus Thrombectomy System for aspiration thrombectomy in subjects with acute pulmonary embolism.

What is the current status of trial NCT05907564?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 130 participants. The study started on 2023-09-20. Estimated completion is 2026-10.

What conditions does trial NCT05907564 study?

This clinical trial studies the following conditions: Cardiovascular Diseases, Pulmonary Embolism, Vascular Diseases, Lung Diseases, Respiratory Tract Diseases.

What interventions are being tested in trial NCT05907564?

The interventions under investigation include: Thrombectomy (DEVICE).

Who is sponsoring clinical trial NCT05907564?

This trial is sponsored by Inquis Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05907564 being conducted?

This trial has 20 study locations across Arizona, California, Connecticut, District of Columbia, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05907564's enrollment target sits among peer trials

130 175th of 300 higher than 125 of 300 other Cardiovascular Diseases trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01492036 · 130 participants

    Long-Term Follow-Up of Recipient of Gene Transfer Research

  • NCT01631617 · 130 participants · Phase 2

    Effects of Treatments on Atopic Dermatitis

  • NCT02368041 · 130 participants

    Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure

  • NCT02604277 · 130 participants · NA

    Suicidal Behavior in Patients Diagnosed With Bipolar Disorder

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05907564, the US trial registry maintained by the National Library of Medicine. NCT05907564 (mid enrollment · wide site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.